Approval · Notice of Compliance 1371 · 2000
DEFINITY: Notice of Compliance 1371
Issued December 28, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1371
- Date
- December 28, 2000
- Company
- Dupont Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Contrast enhancing imaging agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DEFINITY | 02243173 | Marketed |
Medicinal ingredients
- PERFLUTREN 150 MCL per ML